The Claim
In older adults, once-weekly administration of 6 mg sirolimus does not improve functional or quality-of-life outcomes beyond those achieved with exercise alone and may interfere with expected exercise-induced gains, thereby not supporting the preclinical 'cycling hypothesis' that alternating mTORC1 activation and inhibition enhances training adaptations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a weekly 6 mg dose of the drug sirolimus doesn't help older adults get extra benefits from exercise — and might even cancel out some of the gains they'd normally see.
See the scientific wording
Once-weekly sirolimus 6 mg does not enhance functional or quality-of-life improvements from exercise in older adults and may counteract the expected gains, failing to support the preclinical 'cycling hypothesis' that alternating mTORC1 activation and inhibition could amplify training adaptations.
What the research says
1 studyThe study found that taking weekly sirolimus didn’t help older adults get stronger from exercise and might have even reduced their gains, which supports the idea that it doesn’t boost exercise benefits as hoped.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.